Jamal El-Mosleh
Directeur Général chez ELICERA THERAPEUTICS AB
Profil
Mr. Jamal El-Mosleh is a Chief Executive Officer at Elicera Therapeutics AB.
Mr. El-Mosleh was previously employed as a Chief Executive Officer by Annexin Pharmaceuticals AB and a Chief Executive Officer & IR Contact by Immunicum AB.
He also served on the board at Elypta AB.
He received his graduate degree from Chalmers University of Technology and a graduate degree from Chalmers School of Entrepreneurship.
Postes actifs de Jamal El-Mosleh
| Sociétés | Poste | Début |
|---|---|---|
| ELICERA THERAPEUTICS AB | Directeur Général | 01/01/2020 |
Anciens postes connus de Jamal El-Mosleh
| Sociétés | Poste | Fin |
|---|---|---|
Elypta AB
 Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | Directeur/Membre du Conseil | 01/01/2020 |
| ANNEXIN PHARMACEUTICALS AB | Directeur Général | 01/01/2019 |
| MENDUS AB | Directeur Général | 01/10/2016 |
Formation de Jamal El-Mosleh
| Chalmers University of Technology | Graduate Degree |
| Chalmers School of Entrepreneurship | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MENDUS AB | Health Technology |
| ANNEXIN PHARMACEUTICALS AB | Health Technology |
| ELICERA THERAPEUTICS AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | Technology Services |